CPSC2022-06-30
Mohnark Pharmaceuticals Recalls Lidocaine Topical Anesthetic Cream Due to Failure to Meet Child-Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)
Mohnark Pharmaceuticals Inc., of Davie, Fla.
Hazard
The product contains lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging is not child resistant, posing a risk of poisoning to young children if they ingest the anesthetic cream.
Remedy
Consumers should immediately stop using the recalled cream and store it in a location out of sight and reach of children. Contact Mohnark Pharmaceuticals for instructions on how to dispose of the product to receive a full refund. Mohnark Pharmaceuticals is contacting all known purchasers directly.
Sold at
Online at Amazon.com and Walmart.com from January 2021 through January 2022 for about $7.
Affected count
About 9,000
Injuries reported
None reported
Manufactured in
United States
Remedy type
Refund
Products
Lidocaine 4% Topical Anesthetic Cream
Consumer contact
Mohnark Pharmaceuticals toll-free at 866-611-5206 from 9 a.m. to 4 p.m. ET Monday through Friday, or online at www.mohnark.com and click on "RECALL" at the top of the page for more information.
Official notice
https://www.cpsc.gov/Recalls/2022/Mohnark-Pharmaceuticals-Recalls-Lidocaine-Topical-Anesthetic-Cream-Due-to-Failure-to-Meet-Child-Resistant-Packaging-Requirement-Risk-of-Poisoning-Recall-AlertDon't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief